Acta Med. 2012, 55: 42-46
https://doi.org/10.14712/18059694.2015.74
Case 1‑2012: ANCA Associated Glomerulonephritis in Combination with IgG4 Positive Mediastinal Mass in a Patient with Ankylosing Spondylitis Treated with TNF Alpha Inhibitors
References
1. A, Sato K, Itabashi M, et al. A case of Mikuliczes disease complicated with severe interstitial nephritis with IgG4. Clin Exp Nephrol 2009; 13: 367–372.
<https://doi.org/10.1007/s10157-008-0127-5>
2. AC, Deheragoda MG. IgG4‑related systemic sclerosing disease – an emerging and under‑diagnosed condition. Histopathology 2009; 55: 373–83.
<https://doi.org/10.1111/j.1365-2559.2008.03217.x>
3. K, Harper L, Jayne DR, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody‑associated vasculitis: a randomized trial. Ann Rheum Dis. 2009 May 19; 150(10): 670–80.
4. JJ, Carmona L, Valverde VR, Mola EM, Montero MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active‑surveillance report. Arthritis Rheum. 2003; 48(8): 2122–7.
<https://doi.org/10.1002/art.11137>
5. CGM, Heeringa P, Stegeman CA. Mechanisms of Disease: pathogenesis and treatment of ANCA‑associated vasculitides. Nat Clin Pract Reumatol. 2006; 2: 661–70.
<https://doi.org/10.1038/ncprheum0355>
6. T, Okamoto A. IgG4‑related sclerosing disease. World J Gastroenterol 2008; 14: 3948–55.
<https://doi.org/10.3748/wjg.14.3948>
<PubMed>
7. J, Steiner I, Holubec T et al. Isolated thoracic aortitis: clinicopathological and immunohistochemical study of 11 cases. Cardiovasc Pathol. 2011 Nov; 20(6): 352–60. Epub 2010 Oct 30.
<https://doi.org/10.1016/j.carpath.2010.09.003>
8. C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009 Mar; 68(3): 310–7. Epub 2008 Apr 15.
<https://doi.org/10.1136/ard.2008.088096>
9. K, Jarošová K. Výskyt autoimunitních onemocnění po aplikaci biologických léků. Čes. Revmatol. 19, 2011; 1: 4–10.
10. M, van der Heijde D, Landewe R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009; 68: 777–783.
<https://doi.org/10.1136/ard.2009.108233>
11. N, Tashiro T, Uesugi N, et al. IgG4‑positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4‑related sclerosing disease. Am J Surg Pathol 2008; 32: 553–9.
<https://doi.org/10.1097/PAS.0b013e31815a04db>
12. K, Ogawa N, Sawaki T et al. A case of Mikuliczes disease complicted with interstitial nephritis successfully treated by high‑dose corticosteroid. Med Rheumatol 2006; 16: 176–182.
<https://doi.org/10.3109/s10165-006-0478-2>
13. , JH, Yoh Zen, MPH, Deshpande, V: IgG4‑related disease. N. Engl. J. Med. 2012; 366: 539–551.
<https://doi.org/10.1056/NEJMra1104650>
14. SM, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984; 27: 361–368.
<https://doi.org/10.1002/art.1780270401>
15. K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. 491 Chronic pancreatitis caused by an autoimmune abnormality: proposal 492 of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40: 493 1561–8.
